Evaluating clinical experience from a case of hepatocellular carcinoma with combinated therapy of transarterial chemoembolization and percutaneousethanol injection afterward emerging metatasis caused by fine needle aspiration cytology
- Author:
Long Cong Nguyen
;
Truong Xuan Bui
;
Thong Minh Pham
;
Ho Thi Thu Pham
;
Hung Quoc Nghiem
;
Phuong Minh Tran
;
Long Van Dao
;
Trach Khanh Nguyen
- Publication Type:Journal Article
- Keywords:
Hepatocellular carcinoma;
combinated therapy;
transarterial chemoembolization;
percutaneousethanol
- MeSH:
Carcinoma;
Hepatocellular/ pathology;
therapy
- From:Journal of Medical Research
2007;47(2):69-73
- CountryViet Nam
- Language:Vietnamese
-
Abstract:
Background: Hepatocellular carcinoma (HCC) is the most common primary hepatic tumor and one of the most common cancers worldwide. HCC is a primary malignancy of hepatocellular origin. Objectives:The aim of study is to combinate therapy of transarterial chemoembolization and percutaneousethanol injection afterward emerging metatasis caused by fine needle aspiration cytology. Subjects and method: A 50 years old male patient with hepatocellular carcinoma having a diameter of tumor more than 5 cm was treated by combination of transarterial chemoembolization and percutaneous ethanol injection from December 2000. Results & Conclusion: Results of study showed that: Transarterial chemoembolization and percutaneous ethanol injection are the two of non-surgical methods for treatment of hepatocellular carcinoma which are most commonly available in applied clinical activities at present. Up to now, the patient's life expectancy after therapy is more than 6 years that means the result of treatment is very good. However, the emerging metatasis into the anterior-right-Iower chest wall that was caused by fine needle aspiration cytology should be reviewed for further evaluating clinical experience, especially in cases with quite clear imaging features of untrasonography and significantly elevated AFP level higher than 200 ng/rnl.
